Cyclin D1, a Novel Molecular Marker of Minimal Residual Disease, in Metastatic Neuroblastoma

Accurate monitoring of minimal residual disease (MRD) is critical for the management of metastatic neuroblastoma (NB). We evaluated cyclin D1 (CCND1), a cell-cycle control gene, as a novel MRD marker of NB. Using quantitative reverse transcriptase-polymerase chain reaction, we studied CCND1 expressi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cheung, Irene Y., Feng, Yi, Vickers, Andrew, Gerald, William, Cheung, Nai-Kong V.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Investigative Pathology 2007
Assuntos:
Regular Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1867438/
https://ncbi.nlm.nih.gov/pubmed/17384216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/jmoldx.2007.060130
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados